Amazon.com Inc. earned $5.2 billion in the second quarter to double its net income from last year and realize the biggest profit in its 26-year history despite spending around $4 billion on COVID-19 related expenses.
Online store sales surged 48 percent to $45.9 billion during the quarter.
Meanwhile, business from third-party merchants resulted in a 52 percent jump and a 41 percent increase in other revenue, such as from ads.
Amazon founder Jeff Bezos called its performance "highly unusual."
The company forecasted losing money in the second quarter due to $4 billion COVID-19 related expenditures, mainly on staff protective equipment.
According to Investing.com senior analyst Jesse Cohen, Amazon's business model sets it up for more expansion as the global pandemic continues to flare.
Revenue from Amazon Web Services (AWS), which sells cloud computing power and data storage, surged nearly 29 percent to $10.81 billion as companies switched to virtual offices due to the pandemic.
.
According to Amazon's chief financial officer Brian Olsavsky, the profit surprised them because, at the time of its forecast last quarter, shoppers were buying lower-margin products such as masks, gloves, and groceries were not "super-profitable."
However, in the second quarter, product choices started to shift back to normal and that they were able to ship a lot more than originally expected.
Amazon also benefitted from a step up in customer spending in Europe and Japan during the pandemic.
Shares rose five percent in after-hours trade.
Amazon's shares have risen by over 60 percent this year.


SK Hynix Shares Surge on Record $28.6 Billion Buyback
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3 



